Structural basis for glycogen recognition by AMP-activated protein kinase.

AMP-activated protein kinase (AMPK) coordinates cellular metabolism in response to energy demand as well as to a variety of stimuli. The AMPK beta subunit acts as a scaffold for the alpha catalytic and gamma regulatory subunits and targets the AMPK heterotrimer to glycogen. We have determined the structure of the AMPK beta glycogen binding domain in complex with beta-cyclodextrin. The structure reveals a carbohydrate binding pocket that consolidates all known aspects of carbohydrate binding observed in starch binding domains into one site, with extensive contact between several residues and five glucose units. beta-cyclodextrin is held in a pincer-like grasp with two tryptophan residues cradling two beta-cyclodextrin glucose units and a leucine residue piercing the beta-cyclodextrin ring. Mutation of key beta-cyclodextrin binding residues either partially or completely prevents the glycogen binding domain from binding glycogen. Modeling suggests that this binding pocket enables AMPK to interact with glycogen anywhere across the carbohydrate's helical surface.

[1]  W. G. Wiles,et al.  Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo , 2004, Journal of Biological Chemistry.

[2]  M. Parker,et al.  Crystallization of the glycogen-binding domain of the AMP-activated protein kinase beta subunit and preliminary X-ray analysis. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[3]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[4]  Y. Uchijima,et al.  Glycogen debranching enzyme association with beta-subunit regulates AMP-activated protein kinase activity. , 2005, American journal of physiology. Endocrinology and metabolism.

[5]  G Williamson,et al.  Solution structure of the granular starch binding domain of Aspergillus niger glucoamylase bound to beta-cyclodextrin. , 1997, Structure.

[6]  Y. Hellsten,et al.  Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. , 2003, American journal of physiology. Endocrinology and metabolism.

[7]  B. Kemp,et al.  Intrasteric control of AMPK via the γ1 subunit AMP allosteric regulatory site , 2004 .

[8]  M. Carlson,et al.  Gal83 mediates the interaction of the Snf1 kinase complex with the transcription activator Sip4 , 1999, The EMBO journal.

[9]  David Carling,et al.  Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .

[10]  L. Bertrand,et al.  Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. , 2002, Journal of molecular and cellular cardiology.

[11]  L. Johnson,et al.  Protein-oligosaccharide interactions: lysozyme, phosphorylase, amylases. , 1988, Current topics in microbiology and immunology.

[12]  B. Kemp,et al.  Expression of the AMP‐activated protein kinase β1 and β2 subunits in skeletal muscle , 1999 .

[13]  D J Campbell,et al.  AMP-activated protein kinase, super metabolic regulator. , 2001, Biochemical Society transactions.

[14]  E A Merritt,et al.  Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.

[15]  J. Preiss,et al.  The X-ray Crystallographic Structure ofEscherichia coli Branching Enzyme* , 2002, The Journal of Biological Chemistry.

[16]  D. Hardie,et al.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. , 2004, The Journal of clinical investigation.

[17]  J. Seidman,et al.  Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.

[18]  R M Esnouf,et al.  Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.

[19]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[20]  J. Pringle,et al.  Characterization of glycogen-deficient glc mutants of Saccharomyces cerevisiae. , 1994, Genetics.

[21]  B. Kemp,et al.  Isoform-specific Purification and Substrate Specificity of the 5′-AMP-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[22]  V. Lumbreras,et al.  Domain fusion between SNF1‐related kinase subunits during plant evolution , 2001, EMBO reports.

[23]  G J Barton,et al.  ALSCRIPT: a tool to format multiple sequence alignments. , 1993, Protein engineering.

[24]  N. Oikonomakos,et al.  The binding of β‐ and γ‐cyclodextrins to glycogen phosphorylase b: Kinetic and crystallographic studies , 2003, Protein science : a publication of the Protein Society.

[25]  B. Kemp,et al.  Functional Domains of the α1 Catalytic Subunit of the AMP-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[26]  F. Rolland,et al.  Sugar Sensing and Signaling in Plants Article, publication date, and citation information can be found at www.plantcell.org/cgi/doi/10.1105/tpc.010455. , 2002, The Plant Cell Online.

[27]  B. Kemp,et al.  Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. , 2001 .

[28]  J. Wojtaszewski,et al.  Regulation of glycogen synthase activity and phosphorylation by exercise , 2004, The Proceedings of the Nutrition Society.

[29]  C. Rogel-Gaillard,et al.  A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. , 2000, Science.

[30]  B. Kemp,et al.  AMP-activated Protein Kinase β Subunit Tethers α and γ Subunits via Its C-terminal Sequence (186–270)* , 2005, Journal of Biological Chemistry.

[31]  Jiahuai Han,et al.  Stimulation of Glucose Transport by AMP-activated Protein Kinase via Activation of p38 Mitogen-activated Protein Kinase* , 2001, The Journal of Biological Chemistry.

[32]  J. Sacchettini,et al.  The 2.0-A resolution structure of soybean beta-amylase complexed with alpha-cyclodextrin. , 1993, Biochemistry.

[33]  D. Hardie,et al.  New roles for the LKB1-->AMPK pathway. , 2005, Current opinion in cell biology.

[34]  D. Vertommen,et al.  Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis , 2002, Current Biology.

[35]  M. Lawrence,et al.  CONSCRIPT: a program for generating electron density isosurfaces for presentation in protein crystallography , 2000 .

[36]  B. Kemp,et al.  Mutations in the Gal83 Glycogen-Binding Domain Activate the Snf1/Gal83 Kinase Pathway by a Glycogen-Independent Mechanism , 2004, Molecular and Cellular Biology.

[37]  J. James,et al.  A Novel Domain in AMP-Activated Protein Kinase Causes Glycogen Storage Bodies Similar to Those Seen in Hereditary Cardiac Arrhythmias , 2003, Current Biology.

[38]  M. Lazar,et al.  Regulation of Fasted Blood Glucose by Resistin , 2004, Science.

[39]  B. Kemp,et al.  AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen , 2003, Current Biology.

[40]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[41]  L. Dijkhuizen,et al.  Crystallographic Studies of the Interaction of Cyclodextrin Glycosyltransferase from Bacillus circulans Strain 251 with Natural Substrates and Products (*) , 1995, The Journal of Biological Chemistry.

[42]  G. Taffet,et al.  Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White Syndrome , 2005, Circulation.

[43]  H. Watkins,et al.  Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. , 2001, Human molecular genetics.

[44]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[45]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[46]  B. Canny,et al.  AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. , 2000, American journal of physiology. Endocrinology and metabolism.

[47]  Y. Hellsten,et al.  Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. , 2002, Diabetes.

[48]  Young-Bum Kim,et al.  Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.

[49]  S. Sprang,et al.  Structure of maltoheptaose by difference Fourier methods and a model for glycogen. , 1982, Journal of molecular biology.

[50]  J. Shearer,et al.  New perspectives on the storage and organization of muscle glycogen. , 2002, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[51]  Bruce E. Kemp,et al.  Regulation of 5′-AMP-activated Protein Kinase Activity by the Noncatalytic β and γ Subunits* , 1996, The Journal of Biological Chemistry.

[52]  David Carling,et al.  The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[53]  W. Winder,et al.  Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. , 2002, Journal of applied physiology.

[54]  G. Williamson,et al.  Interaction of beta-cyclodextrin with the granular starch binding domain of glucoamylase. , 1991, Biochimica et biophysica acta.

[55]  A. Saltiel,et al.  PTG, a Protein Phosphatase 1-Binding Protein with a Role in Glycogen Metabolism , 1997, Science.

[56]  B. Viollet,et al.  The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. , 2004, Diabetes.

[57]  B. Kemp,et al.  Dealing with energy demand: the AMP-activated protein kinase. , 1999, Trends in biochemical sciences.

[58]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[59]  S. Larson,et al.  Refined Molecular Structure of Pig Pancreatic α-Amylase at 2·1 Å Resolution , 1994 .

[60]  B. Kemp,et al.  Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.

[61]  Ferhaan Ahmad,et al.  Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.

[62]  M. Gollob,et al.  PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy , 2002, Current opinion in cardiology.

[63]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.